Corteva, Inc. $CTVA Shares Purchased by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Corteva, Inc. (NYSE:CTVA) by 3.0% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 3,903,828 shares of the company’s stock after acquiring an additional 113,564 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.59% of Corteva worth $330,615,000 as of its most recent filing with the SEC.

Other institutional investors also recently made changes to their positions in the company. New Mexico Educational Retirement Board increased its holdings in shares of Corteva by 8.8% in the 2nd quarter. New Mexico Educational Retirement Board now owns 33,547 shares of the company’s stock valued at $2,841,000 after purchasing an additional 2,700 shares in the last quarter. Mufg Securities Americas Inc. boosted its holdings in Corteva by 8.2% during the second quarter. Mufg Securities Americas Inc. now owns 20,144 shares of the company’s stock worth $1,706,000 after buying an additional 1,535 shares in the last quarter. Ferguson Wellman Capital Management Inc. grew its position in Corteva by 1.0% during the second quarter. Ferguson Wellman Capital Management Inc. now owns 17,228 shares of the company’s stock worth $1,459,000 after buying an additional 172 shares during the period. Nissay Asset Management Corp Japan grew its position in Corteva by 3.3% during the second quarter. Nissay Asset Management Corp Japan now owns 89,625 shares of the company’s stock worth $7,590,000 after buying an additional 2,828 shares during the period. Finally, Wellington Management Group LLP increased its holdings in Corteva by 941.7% in the second quarter. Wellington Management Group LLP now owns 7,612,704 shares of the company’s stock valued at $644,720,000 after buying an additional 6,881,875 shares in the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Corteva Trading Up 1.0%

Shares of Corteva stock opened at $84.74 on Tuesday. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $90.97. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.52 and a quick ratio of 1.10. The business has a 50 day moving average price of $82.81 and a 200 day moving average price of $80.66. The company has a market capitalization of $56.54 billion, a P/E ratio of 56.12, a P/E/G ratio of 2.58 and a beta of 0.57.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to analysts’ expectations of $6.60 billion. During the same quarter in the prior year, the firm earned $2.20 EPS. Corteva’s quarterly revenue was down 1.2% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CTVA. BNP Paribas Exane boosted their price target on Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Weiss Ratings cut Corteva from a “hold (c+)” rating to a “hold (c)” rating in a report on Monday, August 3rd. Oppenheimer boosted their target price on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. JPMorgan Chase & Co. upped their target price on Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a report on Monday, August 3rd. Finally, Deutsche Bank Aktiengesellschaft restated a “buy” rating and issued a $101.00 price target on shares of Corteva in a research report on Monday, August 3rd. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company’s stock. According to data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.